Solid Biosciences (SLDB) Current Assets (2017 - 2024)
Historic Current Assets for Solid Biosciences (SLDB) over the last 8 years, with Q3 2024 value amounting to $179.5 million.
- Solid Biosciences' Current Assets rose 2099.69% to $179.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $179.5 million, marking a year-over-year increase of 2099.69%. This contributed to the annual value of $129.7 million for FY2023, which is 4093.28% down from last year.
- As of Q3 2024, Solid Biosciences' Current Assets stood at $179.5 million, which was up 2099.69% from $197.6 million recorded in Q2 2024.
- In the past 5 years, Solid Biosciences' Current Assets ranged from a high of $274.3 million in Q1 2021 and a low of $27.2 million during Q3 2020
- Its 5-year average for Current Assets is $170.6 million, with a median of $179.5 million in 2024.
- As far as peak fluctuations go, Solid Biosciences' Current Assets tumbled by 7606.7% in 2020, and later soared by 77920.62% in 2021.
- Solid Biosciences' Current Assets (Quarter) stood at $158.9 million in 2020, then soared by 40.09% to $222.6 million in 2021, then decreased by 1.34% to $219.6 million in 2022, then plummeted by 40.93% to $129.7 million in 2023, then skyrocketed by 38.36% to $179.5 million in 2024.
- Its last three reported values are $179.5 million in Q3 2024, $197.6 million for Q2 2024, and $214.2 million during Q1 2024.